CMS recently released an updated memorandum, “Update to Frequently Asked Questions Related to the Medicare Prescription Payment Plan” from Jennifer R. Shapiro, Director, Medicare Plan Payment Group. Originally released in October 2024, this updated memorandum includes a new FAQ addressing the eligibility of drugs covered by a pharmaceutical manufacturer patient assistance program (PAP) for the Medicare Prescription Payment Plan.
- See the full FAQ here.